However, in CML, prolonged treatment with IFN-α upon TKI withdrawal has been associated with expansion of immunoregulatory cells and lower frequencies of mature CD56dim NK cell (159). Here, IFNA1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.